Form4.ai tracks every SEC insider trade in real time. See every BCAX insider filing with a free account — no card.
See every BCAX insider filing — free account, no card.
Free accountBicara Therapeutics Inc. (BCAX) has 5 SEC Form 4 insider filings on record in the last 90 days. Most recent filing: Sept. 10, 2026.
Open-market value, last 90 days
No open-market buys or sales in this period.
Form 4 filings by type, last 90 days
| Date | Insider | Trade | Value | Price since buy |
|---|---|---|---|---|
| Sep 10, 2026 SEC filing | Cohlhepp Ryan President, COO & Interim CEO | Cashless exercise | $334,394 | — |
| Aug 12, 2026 SEC filing | Cohlhepp Ryan President and COO | Cashless exercise | $453,474 | — |
| Aug 12, 2026 SEC filing | Mazumdar Claire Chief Executive Officer | Cashless exercise | $241,852 | — |
Create a free account to see all 5 BCAX filings from the last 90 days. No card needed.
Create free accountWant BCAX insider buys the moment they're filed, with Telegram alerts? Try Pro free for 7 days
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.